4-Phenylureido/thioureido-substituted 2,2-dimethylchroman analogs of cromakalim bearing a bulky 'carbamate' moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion.

[1]  B. Pirotte,et al.  Influence of the alkylsulfonylamino substituent located at the 6-position of 2,2-dimethylchromans structurally related to cromakalim: from potassium channel openers to calcium entry blockers? , 2014, European journal of medicinal chemistry.

[2]  T. Yorifuji.  Congenital hyperinsulinism: current status and future perspectives , 2014, Annals of pediatric endocrinology & metabolism.

[3]  A. Wojtovich,et al.  Direct Activation of β-Cell KATP Channels with a Novel Xanthine Derivative , 2014, Molecular Pharmacology.

[4]  Alison M. Thomas,et al.  The role of ATP‐sensitive potassium channels in cellular function and protection in the cardiovascular system , 2014, British journal of pharmacology.

[5]  A. Tabarin,et al.  Treatment: symptomatic treatment of hypoglycaemia. , 2013, Annales d'endocrinologie.

[6]  C. Paulmann,et al.  A comparison of electron density from Hirshfeld-atom refinement, X-ray wavefunction refinement and multipole refinement on three urea derivatives , 2013 .

[7]  T. Shibasaki,et al.  Treating diabetes today: a matter of selectivity of sulphonylureas , 2012, Diabetes, obesity & metabolism.

[8]  S. Dilly,et al.  Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulin releasing process. , 2011, Bioorganic & medicinal chemistry.

[9]  C. Michaux,et al.  Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels. , 2011, Journal of medicinal chemistry.

[10]  Barbara Becker,et al.  N,N′-Diphenylthiourea acetone monosolvate , 2010, Acta crystallographica. Section E, Structure reports online.

[11]  P. Tullio,et al.  New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position. , 2009, Bioorganic & medicinal chemistry.

[12]  J. Wouters,et al.  New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers. , 2008, Bioorganic & medicinal chemistry.

[13]  Michael A. Burke,et al.  The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the KATP Channel , 2008, Circulation research.

[14]  B. Pirotte,et al.  KATP channel openers: tissue selectivity of original 3-alkylaminopyrido- and 3-alkylaminobenzothiadiazine 1,1-dioxides. , 2008, Biochemical pharmacology.

[15]  B. Pirotte,et al.  Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim. , 2006, Journal of medicinal chemistry.

[16]  Dinesh,et al.  Synthesis, x-ray structure and N-H…O interactions in 1,3-d iphenyl-urea , 2006 .

[17]  Colin G. Nichols,et al.  KATP channels as molecular sensors of cellular metabolism , 2006, Nature.

[18]  A. George,et al.  Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Makielski,et al.  Function and distribution of the SUR isoforms and splice variants. , 2005, Journal of molecular and cellular cardiology.

[20]  A. Terzic,et al.  K(ATP) channel therapeutics at the bedside. , 2005, Journal of molecular and cellular cardiology.

[21]  P. Arkhammar,et al.  Arylcyanoguanidines as activators of Kir6.2/SUR1K ATP channels and inhibitors of insulin release. , 2004, Journal of medicinal chemistry.

[22]  J. Sturis,et al.  NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat. , 2003, Diabetes.

[23]  S. Seino,et al.  Physiological and pathophysiological roles of ATP-sensitive K+ channels. , 2003, Progress in biophysics and molecular biology.

[24]  F. Ashcroft,et al.  The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. , 2002, Diabetes.

[25]  B. Pirotte,et al.  Synthesis and characterization of a quinolinonic compound activating ATP‐sensitive K+ channels in endocrine and smooth muscle tissues , 2001, British journal of pharmacology.

[26]  P. Arkhammar,et al.  A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release , 2000, Diabetologia.

[27]  S. Seino,et al.  ATP-sensitive potassium channels: structures, functions, and pathophysiology. , 1998, The Japanese journal of physiology.

[28]  K. Sivakumar,et al.  Symmetrically Substituted Thiourea Derivatives , 1995 .

[29]  A. Herchuelz,et al.  A pyridothiadiazine (BPDZ 44) as a new and potent activator of ATP-sensitive K+ channels. , 1994, Biochemical pharmacology.

[30]  A. Herchuelz,et al.  Ionic and secretory response of pancreatic islet cells to minoxidil sulfate. , 1991, The Journal of pharmacology and experimental therapeutics.

[31]  Y. Imaizumi,et al.  Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries. , 1990, The Journal of pharmacology and experimental therapeutics.

[32]  A. Herchuelz,et al.  Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets. , 1989, The Journal of pharmacology and experimental therapeutics.

[33]  N. Standen,et al.  Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. , 1989, Science.

[34]  U. Quast,et al.  In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. , 1989, The Journal of pharmacology and experimental therapeutics.

[35]  D. Cook,et al.  Intracellular ATP directly blocks K+ channels in pancreatic B-cells , 1984, Nature.

[36]  P. Tullio,et al.  Selective pancreatic ATP-sensitive potassium channel openers for the treatment of glucose homeostasis disorders , 2006 .

[37]  S. Seino.  ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. , 1999, Annual review of physiology.

[38]  F. Ashcroft,et al.  The essential role of the Walker A motifs of SUR 1 in K-ATP channel activation by Mg-ADP and diazoxide result in the closure of K-ATP channels in the β-cell plasma , 1997 .

[39]  F. Ashcroft.  Adenosine 5'-triphosphate-sensitive potassium channels. , 1988, Annual review of neuroscience.